Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Demeter

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Orvosi Hetilap|January 22, 2013
[Recurrent somatic mutation in hairy cell leukemia]Eszter Sári, Zsolt Nagy, Judit Demeter
Annals of Hematology|November 9, 2002
Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemiaJudit Demeter, Gerald Messer, Hubert Schrezenmeier
Magyar Onkologia|June 9, 2016
[The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma]Melinda Paksi, Judit Demeter, Péter Szabó
Magyar Onkologia|June 9, 2016
[Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment]Ildikó Istenes, Zsolt Nagy, Judit Demeter
Annals of Hematology|September 27, 2006
The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndromeJudit Várkonyi, Judit Demeter, Attila Tordai, et al.
Orvosi Hetilap|January 7, 2014
[Diagnosis and treatment of primary testicular non-Hodgkin lymphoma]Miklós Romics, Judit Demeter, Imre Romics, et al.
Orvosi Hetilap|September 13, 2016
[Chronic myelogenous leukemia: diagnosis and treatment]Judit Demeter, Anna Poros, Csaba Bödör, et al.
Pathology Oncology Research : POR|March 6, 2024
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from HungaryPeter Batar, Hussain Alizadeh, Gyorgy Rokszin, et al.
Pathology Oncology Research : POR|April 5, 2024
Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from HungaryPeter Batar, Hussain Alizadeh, Gyorgy Rokszin, et al.
Pathology Oncology Research : POR|November 8, 2015
Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre ExperienceImelda Marton, László Krenács, Enikő Bagdi, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Orvosi Hetilap|January 22, 2013
[Recurrent somatic mutation in hairy cell leukemia]Eszter Sári, Zsolt Nagy, Judit Demeter
Annals of Hematology|November 9, 2002
Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemiaJudit Demeter, Gerald Messer, Hubert Schrezenmeier
Magyar Onkologia|June 9, 2016
[The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma]Melinda Paksi, Judit Demeter, Péter Szabó
Magyar Onkologia|June 9, 2016
[Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment]Ildikó Istenes, Zsolt Nagy, Judit Demeter
Annals of Hematology|September 27, 2006
The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndromeJudit Várkonyi, Judit Demeter, Attila Tordai, et al.
Orvosi Hetilap|January 7, 2014
[Diagnosis and treatment of primary testicular non-Hodgkin lymphoma]Miklós Romics, Judit Demeter, Imre Romics, et al.
Orvosi Hetilap|September 13, 2016
[Chronic myelogenous leukemia: diagnosis and treatment]Judit Demeter, Anna Poros, Csaba Bödör, et al.
Pathology Oncology Research : POR|March 6, 2024
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from HungaryPeter Batar, Hussain Alizadeh, Gyorgy Rokszin, et al.
Pathology Oncology Research : POR|April 5, 2024
Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from HungaryPeter Batar, Hussain Alizadeh, Gyorgy Rokszin, et al.
Pathology Oncology Research : POR|November 8, 2015
Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre ExperienceImelda Marton, László Krenács, Enikő Bagdi, et al.
Pageof 9